Description: | Sequence 50 from Patent EP1749840. Sequence 50 from patent US 5783184. Sequence 50 from patent US 5851525. Sequence 50 from patent US 6129913. Sequence 50 from patent US 6946130. Sequence 50 from patent US 5683892. Sequence 50 from patent US 5693323. Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders. IMPROVED METHOD FOR TREATMENT AND DIAGNOSIS OF IL-5 MEDIATED DISORDERS. Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders. Sequence 50 from patent US 7399837. Sequence 50 from patent US 7982005. JP 2000515494-A/34: Improved method for treating and diagnosing IL-5-mediated disorder. | |
Length: | 5703 bp | |
Found in databases: | nrnl1 | |
Found in the following 15 patents: | EP1749840 (lens, espacenet) US5783184 (lens, espacenet) US5851525 (lens, espacenet) US6129913 (lens, espacenet) US6946130 (lens, espacenet) US2004156850 (lens, espacenet) US5683892 (lens, espacenet) US5693323 (lens, espacenet) JP2008029355 (lens, espacenet) JP2008189666 (lens, espacenet) JP2010077133 (lens, espacenet) US7399837 (lens, espacenet) US2006029594 (lens, espacenet) US7982005 (lens, espacenet) JP2000515494 (lens, espacenet) |
View these methods in JRC GMO-Matrix
Event-specific method | |
Element-specific method | |
Construct-specific method | |
Taxon-specific method |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
NRN_CS622375 | nrnl1 | Sequence 50 from Patent EP1749840. ... | 5703 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
NRN_CS622375 | nrnl1 | Sequence 50 from Patent EP1749840. ... | 5703 bp | unidentified | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.